Results from the sequencing of 200 patients with advanced EGFR mutated NSCLC identified co-occurring mutations in TP53, PIK3CA, catenin beta-1 (CTNNB1), and RB1 [39]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.